Two-Year Outcomes with Fully Repositionable Aortic Valve in High Surgical Risk Patients

The REPRISE II trial extended cohort evaluated the Lotus Valve System's safety and performance in symptomatic patients with severe aortic stenosis at high risk for surgical valve replacement. This prospective, single-arm study assessed the valve system's effectiveness through various follow-ups and

0 views • 19 slides